MCC
TBPH icon

Money Concepts Capital’s Theravance Biopharma TBPH Stock Holding History

Money Concepts Capital’s Portfolio TBPH Stock Details TBPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$711K Buy
+41,848
New +$693K 0.03% 361

Other funds holding TBPH

CAMG
CWA Asset Management Group Naples, Florida $3.28B AUM 34.07% 1-Year Est. Return
WCM
Wedge Capital Management Charlotte, North Carolina $6.06B AUM 47.24% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
SSA
Sierra Summit Advisors Incline Village, Nevada $895M AUM 106% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return
AA
ALPS Advisors Denver, Colorado $21.3B AUM 23.41% 1-Year Est. Return
SO
STRS Ohio Columbus, Ohio $26.7B AUM 43.32% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
Mitsubishi UFJ Trust & Banking
Mitsubishi UFJ Trust & Banking Tokyo, Japan $45.7B AUM 34.08% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $114B AUM 41.71% 1-Year Est. Return

Money Concepts Capital's TBPH Position: Q2 2026 in Review

Money Concepts Capital opened a new position in Theravance Biopharma (TBPH) in Q2 2026: 41,848 shares worth $711K. The stake represents 0.03% of the portfolio and ranks #361 among its holdings.

46 funds tracked by Wall St. Rank hold TBPH as of Q2 2026.

  • Money Concepts Capital held 41,848 shares of Theravance Biopharma worth $711K as of Q2 2026.
  • Theravance Biopharma was a new Money Concepts Capital position in Q2 2026.
  • Theravance Biopharma made up 0.03% of Money Concepts Capital's portfolio in Q2 2026, its #361 holding.
  • 46 funds tracked by Wall St. Rank held Theravance Biopharma as of Q2 2026.

Based on Money Concepts Capital's 13F filing for Q2 2026, filed 4 Aug 2026.